These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14975260)

  • 1. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes).
    Durandy A; Revy P; Fischer A
    Adv Immunol; 2004; 82():295-330. PubMed ID: 14975260
    [No Abstract]   [Full Text] [Related]  

  • 2. Defects of class-switch recombination.
    Notarangelo LD; Lanzi G; Peron S; Durandy A
    J Allergy Clin Immunol; 2006 Apr; 117(4):855-64. PubMed ID: 16630945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically acquired class-switch recombination defects: the multi-faced hyper-IgM syndrome.
    Erdos M; Durandy A; Maródi L
    Immunol Lett; 2005 Feb; 97(1):1-6. PubMed ID: 15626470
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulin class switch recombination deficiencies.
    Kracker S; Gardes P; Mazerolles F; Durandy A
    Clin Immunol; 2010 May; 135(2):193-203. PubMed ID: 20167540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin class switching: in vitro induction and analysis.
    Kracker S; Radbruch A
    Methods Mol Biol; 2004; 271():149-59. PubMed ID: 15146119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
    Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
    J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2.
    Imai K; Zhu Y; Revy P; Morio T; Mizutani S; Fischer A; Nonoyama S; Durandy A
    Clin Immunol; 2005 Jun; 115(3):277-85. PubMed ID: 15893695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair.
    Péron S; Pan-Hammarström Q; Imai K; Du L; Taubenheim N; Sanal O; Marodi L; Bergelin-Besançon A; Benkerrou M; de Villartay JP; Fischer A; Revy P; Durandy A
    J Exp Med; 2007 May; 204(5):1207-16. PubMed ID: 17485519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans.
    Weller S; Faili A; Garcia C; Braun MC; Le Deist F F; de Saint Basile G G; Hermine O; Fischer A; Reynaud CA; Weill JC
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1166-70. PubMed ID: 11158612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID in somatic hypermutation and class switch recombination.
    Longerich S; Basu U; Alt F; Storb U
    Curr Opin Immunol; 2006 Apr; 18(2):164-74. PubMed ID: 16464563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation.
    Durandy A
    Biochem Soc Trans; 2002 Aug; 30(4):815-8. PubMed ID: 12196205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyper-IgM syndromes.
    Durandy A; Peron S; Fischer A
    Curr Opin Rheumatol; 2006 Jul; 18(4):369-76. PubMed ID: 16763457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies.
    Durandy A; Taubenheim N; Peron S; Fischer A
    Adv Immunol; 2007; 94():275-306. PubMed ID: 17560278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory.
    Muramatsu M; Nagaoka H; Shinkura R; Begum NA; Honjo T
    Adv Immunol; 2007; 94():1-36. PubMed ID: 17560270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
    Jain A; Ma CA; Lopez-Granados E; Means G; Brady W; Orange JS; Liu S; Holland S; Derry JM
    J Clin Invest; 2004 Dec; 114(11):1593-602. PubMed ID: 15578091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody diversity: one enzyme to rule them all.
    Nussenzweig MC; Alt FW
    Nat Med; 2004 Dec; 10(12):1304-5. PubMed ID: 15580255
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunology. UNGstoppable switching.
    Unniraman S; Fugmann SD; Schatz DG
    Science; 2004 Aug; 305(5687):1113-4. PubMed ID: 15326342
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of Apex2 in class-switch recombination of immunoglobulin genes.
    Guikema JE; Stavnezer J; Schrader CE
    Int Immunol; 2010 Mar; 22(3):213; author reply 213-4. PubMed ID: 20185435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.